TrialCancer immunology, immunotherapy : CII2012

Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer.

Chun-Jian Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.